Manhasset, New York

INDOCHINO DEBUTS BLACK FRIDAY DEALS AND ANNOUNCES THEIR LATEST SHOWROOM EXPANSION

Retrieved on: 
Monday, November 7, 2022
Online, Black Friday, Manhasset, New York, Omnichannel, The Gate, Fur clothing, Retail, Tailor, Newsweek, BC

VANCOUVER, BC, Nov. 7, 2022 /PRNewswire/ -- Today, INDOCHINO, the global leader in custom apparel, announced their slate of 2022 Black Friday Deals. This year's promotions will be the brand's most comprehensive to-date, including a variety of bundles on INDOCHINO's bestselling, made to measure styles.

Key Points: 
  • Notable offers from INDOCHINO's Black Friday 2022 event include:
    In addition to INDOCHINO's Black Friday deals, the custom apparel brand is excited to announce their newest showroom at The Gate at Manhasset shopping center in Long Island, New York.
  • Customers can begin booking appointments now to visit this new showroom and shop INDOCHINO's exciting Black Friday 2022 event.
  • Learn more and view all showroom locations at: www.indochino.com/showrooms
    As the global leader in made to measure apparel, INDOCHINO has developed the shopping experience of the future.
  • The company's omni-channel approach allows them to shop online or in person at any INDOCHINO showroom.

Feinstein Institutes’ Research Journal Molecular Medicine Increases Impact Factor

Retrieved on: 
Thursday, July 29, 2021
Health, Other Health, Other Science, General Health, Research, Science, Academic journals, Feinstein Institute for Medical Research, Manhasset, New York, Open access journals, Academic publishing, Mass media, Molecular Medicine, BioMed Central, Molecular Medicine

The impact factor of the international peer-reviewed medical research journal Molecular Medicine , which is published by The Feinstein Institutes for Medical Research and Springer Natures BioMed Central, rose to 6.354 the highest score since the publication was founded in 1994.

Key Points: 
  • The impact factor of the international peer-reviewed medical research journal Molecular Medicine , which is published by The Feinstein Institutes for Medical Research and Springer Natures BioMed Central, rose to 6.354 the highest score since the publication was founded in 1994.
  • Impact factors help inform fellow researchers about the reach and influence a medical journal has on the larger scientific community and why they should consider submitting their studies for publication, said Betty Diamond, MD, director of the Institute of Molecular Medicine at the Feinstein Institutes and Editor-in-Chief of Molecular Medicine.
  • In addition to Molecular Medicine, the Feinstein Institutes publishes the journal Bioelectronic Medicine in partnership with BioMed Central , part of Springer Nature .
  • Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine.

Investigational Pill for Postpartum Depression Shows Promise in Clinical Trial Led by the Feinstein Institutes

Retrieved on: 
Wednesday, June 30, 2021
Mental health, Health, General Health, Clinical trials, Research, Science, Pharmaceutical, Feinstein Institute for Medical Research, Manhasset, New York, Northwell Health

View the full release here: https://www.businesswire.com/news/home/20210630005797/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210630005797/en/
    Kristina Deligiannidis, MD, associate professor, the Feinstein Institutes for Medical Research (Credit: The Feinstein Institutes for Medical Research)
    PPD is estimated to affect one out of 8 women in the United States .
  • The double-blinded, placebo-controlled clinical trial was led by Kristina Deligiannidis, MD , associate professor at the Feinstein Institutes Institute of Behavioral Science .
  • The Feinstein Institutes and Dr. Deligiannidis continue to pioneer research methods to diagnose and treat perinatal depression depression before and after childbirth.
  • The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State.

Feinstein Institutes Expert Outlines Plan for Advancing Behavioral Research

Retrieved on: 
Monday, June 14, 2021
Mental health, Health, Other Health, General Health, Research, Science, Medicine, Clinical medicine, Psychiatry, Feinstein Institute for Medical Research, Manhasset, New York, Karina W. Davidson, Behavioral medicine, Psychosomatic medicine

In a letter to the editor published today in the journal Nature Human Behaviour , Karina W. Davidson, PhD, MASc , The Feinstein Institutes for Medical Research director of the Institute of Health System Science and national leader in behavioral change research, outlined how the Behavioral Medicine Research Council (BMRC) will progress the field of science.

Key Points: 
  • In a letter to the editor published today in the journal Nature Human Behaviour , Karina W. Davidson, PhD, MASc , The Feinstein Institutes for Medical Research director of the Institute of Health System Science and national leader in behavioral change research, outlined how the Behavioral Medicine Research Council (BMRC) will progress the field of science.
  • View the full release here: https://www.businesswire.com/news/home/20210614005698/en/
    Karina Davidson, PhD, director of the Institute of Health System Science from the Feinstein Institutes for Medical Research (Credit: The Feinstein Institutes for Medical Research)
    The BMRC was formed in 2018 with members across the field of behavioral science's four main professional societies: Academy of Behavioral Medicine, American Psychosomatic Society, Society of Behavioral Medicine Research and Society for Health Psychology.
  • Its mission is to develop a plan to foster scientific discovery in behavioral research by optimizing research practices, scaling and implanting programs and developing new interventions.
  • The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State.

Feinstein Institutes Names Lopa Mishra Co-Director of the Institute of Bioelectronic Medicine

Retrieved on: 
Thursday, May 20, 2021
Health, Other Science, General Health, Clinical trials, Research, Science, Biotechnology, Feinstein Institute for Medical Research, Manhasset, New York, Yousef Al-Abed, Academic journals, Molecular Medicine, Periodicals, Publications

b'The Feinstein Institutes for Medical Research , the science arm of Northwell Health , has named Lopa Mishra, MD, co-director for the Institute of Bioelectronic Medicine .

Key Points: 
  • b'The Feinstein Institutes for Medical Research , the science arm of Northwell Health , has named Lopa Mishra, MD, co-director for the Institute of Bioelectronic Medicine .
  • View the full release here: https://www.businesswire.com/news/home/20210520005187/en/\nLopa Mishra, MD, is the new co-director of the Institute of Bioelectronic Medicine at the Feinstein Institutes.
  • Dr. Mishra will co-lead the Institute with Yousef Al-Abed, PhD , who has been director since 2015.\nDr.
  • Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine.

Say Hello to our New Square Care Center for Maternal Fetal Medicine

Retrieved on: 
Monday, May 17, 2021
Manhasset, New York, Breast imaging, Mammography, Clinical medicine, Medicine

b'MANHASSET, N.Y., May 17, 2021 /PRNewswire-PRWeb/ -- Square Care Medical Group, a multi-specialty group with a focus on women\'s healthcare, is excited to announce the new center for its existing maternal fetal medicine service as it opens the Square Care Center for Maternal Fetal Medicine and Advanced Women\'s Imaging.

Key Points: 
  • b'MANHASSET, N.Y., May 17, 2021 /PRNewswire-PRWeb/ -- Square Care Medical Group, a multi-specialty group with a focus on women\'s healthcare, is excited to announce the new center for its existing maternal fetal medicine service as it opens the Square Care Center for Maternal Fetal Medicine and Advanced Women\'s Imaging.
  • The suite will be located in the office building at 1615 Northern Boulevard in Manhasset, which currently houses multiple Square Care Medical Group offices, including the shared offices of Drs.
  • Trongone and Petrocelli and Premier Women\'s Health, as well as one of our mammography sites, Square Care Breast Imaging at Manhasset.
  • Dr. Michelle Smith-Levitin, director of the new center, has been the dedicated MFM specialist in Square Care Medical Group for four years, operating out of our care centers in Bayside, Woodbury, and Manhasset, NY.

Feinstein Institutes Clinical Research to Study Experimental Stroke Drug

Retrieved on: 
Tuesday, May 11, 2021
Health, Science, Research, Clinical trials, Cardiology, Feinstein Institute for Medical Research, Manhasset, New York, North Shore University Hospital, National Institutes of Health, Stroke, Medical research, Hospitals, Health care, Health

View the full release here: https://www.businesswire.com/news/home/20210511005781/en/\nRichard Temes, MD, Northwell Health\xe2\x80\x99s director, Center for Neurocritical Care (Credit: The Feinstein Institutes for Medical Research)\nThe study, entitled \xe2\x80\x9cRecombinant Factor Vlla (rFVlla) for Acute Hemorrhagic Stroke Administered at Earliest Time,\xe2\x80\x9d also referred to as the FASTEST trial, is funded by the National Institutes of Health (NIH).

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210511005781/en/\nRichard Temes, MD, Northwell Health\xe2\x80\x99s director, Center for Neurocritical Care (Credit: The Feinstein Institutes for Medical Research)\nThe study, entitled \xe2\x80\x9cRecombinant Factor Vlla (rFVlla) for Acute Hemorrhagic Stroke Administered at Earliest Time,\xe2\x80\x9d also referred to as the FASTEST trial, is funded by the National Institutes of Health (NIH).
  • The research will be conducted at North Shore University Hospital (NSUH), a comprehensive stroke center.
  • The study medicine will be given within two hours of stroke onset.
  • Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine.

Feinstein Institutes Receives $3.7M NIH Support for Bioelectronic Medicine Research

Retrieved on: 
Thursday, May 6, 2021
Health, Managed care, Clinical trials, Research, Science, Biotechnology, Feinstein Institute for Medical Research, Manhasset, New York, Academic journals, National Institutes of Health, National Institute of General Medical Sciences, Kevin J. Tracey, Medical research, Molecular Medicine, Health care, Health

b'The Feinstein Institutes for Medical Research , the global scientific home of bioelectronic medicine , has been awarded a five-year grant totaling more than $3.7 million from the National Institutes of Health\xe2\x80\x99s (NIH) National Institute of General Medical Sciences (NIGMS) to support research in the molecular basis of bioelectronic medicine.

Key Points: 
  • b'The Feinstein Institutes for Medical Research , the global scientific home of bioelectronic medicine , has been awarded a five-year grant totaling more than $3.7 million from the National Institutes of Health\xe2\x80\x99s (NIH) National Institute of General Medical Sciences (NIGMS) to support research in the molecular basis of bioelectronic medicine.
  • View the full release here: https://www.businesswire.com/news/home/20210506005048/en/\nKevin J. Tracey, MD, president and CEO of the Feinstein Institutes.
  • (Credit: The Feinstein Institutes for Medical Research)\nBioelectronic medicine explores the use of electronic devices to treat disease and injury through the body\xe2\x80\x99s nervous system instead of pharmaceuticals.
  • Home to 50 research labs, 2,500 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine.

New Schizophrenia Genetic Mutation Discovered by Feinstein Institutes Researchers

Retrieved on: 
Monday, March 22, 2021
Research, Mental health, Genetics, Clinical trials, Other Health, Biotechnology, General Health, Health, Science, Oncology, Feinstein Institute for Medical Research, Manhasset, New York, Northwell Health, Schizophrenia, Kevin J. Tracey, Medical specialties, Mind, Health care

Researchers at The Feinstein Institutes for Medical Research , in collaboration with Columbia University, have identified a gene mutation that could result in schizophrenia, a chronic brain disorder that affects nearly one percent of the worlds population .

Key Points: 
  • Researchers at The Feinstein Institutes for Medical Research , in collaboration with Columbia University, have identified a gene mutation that could result in schizophrenia, a chronic brain disorder that affects nearly one percent of the worlds population .
  • View the full release here: https://www.businesswire.com/news/home/20210322005589/en/
    Todd Lencz, professor in the Institute of Behavioral Science at the Feinstein Institutes.
  • Dr. Lenczs research into the role of genetics in schizophrenia offers a major advance, said Kevin J. Tracey, MD president and CEO of the Feinstein Institutes.
  • The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State.

Feinstein Institutes and GE Research Demonstrate Ultrasound Stimulation Reduces Obesity

Retrieved on: 
Wednesday, March 3, 2021
Biotechnology, Diabetes, Health, General Health, Radiology, Other Science, Medical devices, Research, Fitness & Nutrition, Science, Clinical trials, Feinstein Institute for Medical Research, Manhasset, New York, Obesity, Northwell Health, Health, Medical specialties, Clinical medicine, Obesity-associated morbidity

New research shows that liver-focused ultrasound stimulation significantly decreases chronic inflammation linked to obesity.

Key Points: 
  • New research shows that liver-focused ultrasound stimulation significantly decreases chronic inflammation linked to obesity.
  • In a study published today in Scientific Reports , researchers from the Feinstein Institutes for Medical Research and GE Research demonstrate that ultrasound technology could be used as a noninvasive approach to treating obesity.
  • This important collaboration with GE Research points to future studies that may improve the lives of patients with obesity."
  • The Feinstein Institutes for Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State.